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ABSTRACT 
The long-term goal of stem cell engineering is to generate functional cells for 
cell replacement therapies, disease modelling and in drug development assays. It is 
evident that one of the major challenges in stem cell research is to develop reproducible 
methods to obtain well-defined and pure populations of clinically relevant cell types in a 
sustainable manner. Many studies have shown that appropriate signalling factors can 
specify desired cell types from stem cells, albeit in an inefficient manner. The 
heterogeneity seen in stem cell-derived cultures makes them unsafe and ineffective for 
use in the clinics and laboratories. In this thesis, we applied knowledge obtained from 
early developmental studies to develop rational approaches in stem cell engineering of a 
variety of clinically important cell types. In Paper I, we created mesendodermal 
progenitors by long-term activation of the Wnt pathway using a chemically defined 
inhibitor. These progenitors served as a renewable platform for more efficient stepwise 
derivation of cardiac, endothelial, osteogenic and chondrogenic cells. In Papers II and 
III, we integrated extrinsic and intrinsic cues by creating a permissive environment using 
appropriate growth factors, then forcing the expression of key transcription factors to 
achieve a highly efficient method to generate an array of neuronal cell types including 
dopamine, serotonin, motor and noradrenergic neurons. The purity of the cultures makes 
it possible to analyse subtype-specific genome-wide gene expression patterns and the 
discovery of novel markers provide insight into their transcriptional codes. We also 
showed, in a proof-of-concept experiment that the stem cell-derived neurons can be used 
in high throughput drug assays to analyse drug specificity.  
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1 INTRODUCTION 
1.1 What is stem cell engineering? Why stem cell research? 
In my own words, stem cell engineering is the application of in-vivo knowledge 
to derive clinically-relevant cell types from “stem” cells, in an efficient and sustainable 
manner (inspired by the definition of “engineering” by the American Engineer’s 
Council). Stem-ness is an ability associated with the cell’s multipotency (the potential 
to give rise to its descendents) and its ability to self-renew. It is easy to see why stem 
cell engineering has important applications in therapy – the most straightforward of all 
in regenerative medicine.  
 
1.1.1 Stem cells in regenerative medicine 
In regenerative medicine, we restore normal function in a disorder by replacing 
or regenerating diseased or lost cells. Unlike the salamander that possesses the natural 
ability to regenerate complex structures such as their limbs, tail, neurons, etc, humans 
have a limited capacity for regeneration (Morrison et al., 2006; Parish et al., 2007).  
In disorders whereby cells are diseased or lost for yet unknown/unstoppable 
reasons (e.g. Parkinson’s disease (PD), spinal cord injury, type I diabetes, heart disease, 
etc), cell replacement therapy provides a superior alternative to pharmacological agents 
for symptomatic relief. For instance, drugs such as L-DOPA in PD, or insulin in 
diabetes are not delivered directly to the sites of action and their doses are not titrated 
according to the specific needs of the body; Implanted neurons or pancreatic beta cells 
integrate inputs from their surroundings and deliver appropriate levels outputs to 
specific targets at the appropriate times, minimising side effects seen in therapy by 
pharmacological agents.  
In the clinics today, we already see bone marrow stem cell transplants in 
patients with leukaemia as a life-saving procedure. Neurodegenerative diseases 
represent a plethora of disorders in which therapies are only available for symptom 
relief, and the progressive nature of the disease eventually renders most therapies 
ineffective. At the onset of PD, for example, more than 80% of the dopamine neurons 
would have been lost. In 1986, scientists in Sweden began small clinical trials to 
transplant ventral mesencephalic tissue from aborted foetuses into PD patients 
(Lindvall et al., 1990). The grafted tissue survived and showed signs of innervations, 
leading to promising improvements in some of the patients (Lindvall et al., 1989; 
Lindvall et al., 1992)
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material ranged from promising to being clinically insignificant and were not 
convincing enough to bring cell replacement therapy to the clinics (Freed et al., 1992; 
Freed et al., 2001; Hagell et al., 1999; Olanow et al., 2003; Spencer et al., 1992; Widner 
et al., 1992). In retrospect, this was not surprising because there were, however, glaring 
obstacles in such procedures, the most frustrating of all is contributed by variability in 
preparations of donor tissues used which is already limited in availability (Barker et al., 
2013; Bjorklund and Kordower, 2013; Politis et al., 2011).   
Unlike foetal tissue, which are subjected to ethical issues and are limited in 
availability, ESC-derived neurons represent a potentially unlimited source of neurons 
that can not only be used in transplants, but also as cellular models to understanding 
disease mechanisms or in drug assays. Cells can be generated in a dish under good 
manufacturing practice conditions so that they are safe for human use. The potential for 
stem cell as replacement therapy also applies for other diseases with a degenerative 
nature such as in diabetes, or in organ failures such as heart failures, etc.  
 With advances in surgical techniques, imaging and infection control, the rate-
limiting step now lies in finding methods to derive an efficient and reliable source of 
well-characterised and functional cells for replacement therapy. 
 
1.1.2 Stem cells in disease modelling 
It has become increasingly apparent that cell lines traditionally used to 
understand physiological processes or for toxicity/drug screening are limited in their 
capacity to mimic the in-vivo situation. Commonly used ovarian cancer cell lines, for 
instance, have significantly different mutation and gene expression profiles from what 
is observed in ovarian tumours (Domcke et al., 2013). Cell lines of neuronal origin such 
as PC12 express neural receptors, react to nerve growth factors and even produce 
neurotransmitters such as the catecholamine. Although easy to use, these tumour-
derived immortalized cell lines (PC12 from the rat pheochromocytoma) have abnormal 
genotypes and their genomic instability makes them vulnerable to selection pressures. It 
is possible to carefully characterise cell lines before use but there is still a lack of cell 
lines that represent the myriad of neuronal subtypes present in the nervous system. 
Immortalised hepatocyte cell lines are a valuable resource for studying drug-induced 
hepatotoxicity but they are plagued with problems of genetic instability and poor 
resemblance to in-vivo function (Dalgetty et al., 2009; Delgado et al., 2005; Tachibana 
et al., 2011).  
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ESC-derived cells represent a biologically relevant representation of their in-
vivo counterparts. ESCs possess the potential to give rise to all cell types of the adult 
human body and hence is a source of any cell types needed for study. With the advent 
of the induced pluripotent stem cells (iPSCs), which I will elaborate in a later section, 
stem cell engineering has gained an additional niche in disease modelling of 
developmental disorders with a genetic basis. iPSCs may be the answer to ethical and 
incompatibility issues in heterologous transplants, although it may not be the wisest to 
use material from the same patients who carry the disease-causing genetic defect. Such 
material, however, has unprecedented potential in disease modelling. iPSCs have the 
ability to recapitulate the original genetic defects seen in such patients, providing means 
to analyse, in-vitro, disease mechanisms or to act as tools for drug screening. By 
coaxing iPSCs from patients to develop into the clinically relevant cell types (patient-
specific iPSCs), we can observe, in a dish, processes that go wrong during their early 
development and possibly find ways to correct them. iPSCs derived from Rett 
syndrome patients, for example, can be differentiated into neurons and these neurons 
not only behaved differently, but were also smaller in size (Kim et al., 2011b; 
Marchetto et al., 2010). In neurodegenerative diseases where the underlying cause is 
not as well understood, such as idiopathic Parkinson’s disease, neurons derived from 
patient-specific iPSCs allow us to study cell types that are otherwise lost in the disease 
(Sanchez-Danes et al., 2012b). iPSCs derived from patients with familial or sporadic 
Alzheimer’s disease gave rise to neurons and astrocytes that accumulated amyloid 
peptides, leading to increased oxidative stress (Kondo et al., 2013). Such in-vitro 
systems are particularly important for diseases which lack good animal models to study 
disease mechanisms. 
Taking a step further than merely disease modelling, several groups have 
explored the use of iPSCs in correcting the underlying pathological processes. As a 
proof-of-principle for the potential to cure diseases with the aid of iPSCs and stem cell 
engineering, a group made iPSCs from mice models of sickle cell anaemia, corrected 
the mutation in the haemoglobin gene in-vitro, then differentiated the iPSCs into blood 
forming progenitors that goes on to repopulate the blood with normal red blood cells, 
hence curing the mouse (Hanna et al., 2007). This has very quickly caught on in similar 
experiments in patient-specific human iPSCs with novel strategies to correct the site-
specific mutation (Sebastiano et al., 2011; Zou et al., 2011). 
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1.1.3 Stem cells in toxicity/drug screening 
Besides using these in-vitro engineered cells for transplants, stem cell-derived 
specialised cells can be used in high-throughput drug screening platforms to 
complement complicated and expensive animal testing. Cardiac toxicity, in particularly 
drug-induced arrhythmia, is one of the key concerns in assessing the safety of a new 
drug compound (Kraushaar et al., 2012). There are now extensive studies to assess the 
suitability of stem cell-derived cardiomyocytes to replace primary cultures or non-
cardiogenic cell lines in large-scale in-vitro assays for cardiotoxicity screens (Abassi et 
al., 2012; Kettenhofen and Bohlen, 2008; Ma et al., 2011). Recently, a group has 
created a library of patient-specific iPSC from patients with pre-existing heart disease 
and showed that such iPSC-derived cardiomyocytes recapitulates the drug-induced 
cardiotoxicity profiles seen in the different groups of patients (Liang et al., 2013).  
Other than toxicity screens, stem cells provide an avenue for us to derive in a 
controlled and high-throughput manner, disease- or patient-specific cells to screen for 
drug candidates. Amyotrophic lateral sclerosis patients suffer from degenerating motor 
neurons that is eventually fatal. Motor neurons engineered from patient-specific iPSC 
can be used to screen for chemical compounds that rescue the phenotype, and this was 
shown to be fruitful in the discovery of anacardic acid as a candidate drug (Egawa et 
al., 2012).  
 
The key to success in all the endeavours described above lies in efficient, 
reproducible methods to drive the differentiation of pluripotent stem cells into clinically 
relevant cell types that are homogenous and functional.  
 
1.2 Introducing the embryonic stem cell (ESC) and induced 
pluripotent stem cells (iPSCs) 
 
1.2.1 What is the embryonic stem cell (ESC)? 
In 1981, Evans and Kaufman (Evans and Kaufman, 1981) and Martin (Martin, 
1981) described the isolation of the inner cell mass from mouse blastocysts and 
established in culture under specific conditions, embryonic stem cells (ESC) that are 
self-renewing and retains the potential to give rise to cells of the three germ layers, 
either as teratocarcinomas when transplanted in a mouse, or as outgrowths from 
rounded aggregates of cells (embryoid bodies) when plated on a dish. Such outgrowths 
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were comprised of a random mixture of cell types from the three germ layers. When 
ESCs were derived from human blastocysts in 1998 (Thomson et al., 1998), it became 
even more apparent that ESC research is clinically relevant in terms of regenerative 
medicine and drug screening and opened the floodgates to ESC research.  
The ground state of pluripotency of an embryonic stem cell is often defined 
experimentally by (but not limited to)  -­‐ Gene expression of Oct4, Sox2, Nanog, amidst an array of other markers such 
as Klf4 and Rex1. Conversely, lack of expression of markers of the three germ 
layers such as Foxa2, Sox17, Gata4 (endoderm); T, Hand1 (mesoderm); Sox1, 
Sox3, Pax6(ectoderm).   -­‐ Appearance of cells with a large nuclear-to-cytoplasmic ratio in compact, 
rounded colonies. -­‐ Positive staining for alkaline phosphatase. -­‐ Long-term self-renewal in-vitro. -­‐ Differentiates in-vitro (forms embryoid bodies) and in-vivo (forms teratomas) 
to give rise to cells representative of the three germ layers. -­‐ Ability to significantly contribute to chimeras. 
 
Despite the common theme revolving around Oct4, Sox2 and Nanog in 
governing the pluripotency network of mouse and human ESCs, there are significant 
differences in the signalling pathways involved. Pluripotency of mouse ESCs depends 
on leukaemia inhibitory factor (LIF) and bone morphogenetic factors (BMPs) (Ying et 
al., 2003), whereas human ESCs require activin and fibroblast growth factor (FGF). 
Mouse ESCs express the surface marker SSEA-1 while human ESCs express SSEA-4.  
Such differences motivated researchers to look for an ESC model that is closer 
to their human counterpart and this has led to the discovery of epiblast stem cells 
(EpiSCs) from the mouse in 2007 (Brons et al., 2007). Unlike ESCs, which are 
obtained from the ICM at earlier pre-implantation stages, EpiSCs are obtained from 
post-implantation epiblast cells just before gastrulation (E5.5-7.5). Like ESCs, they 
express Oct4, Sox2 and Nanog and have the ability to give rise to cells of the three 
germ layers both in-vitro and in-vivo. Unlike mouse ESCs, mouse EpiSCs more closely 
resemble human ESC in terms of their appearance (larger colonies in a monolayer), 
response to activin and FGFs in culture to maintain pluripotency (and the lack of 
response to LIF) and the pluripotency transcriptional network (Tesar et al., 2007). Due 
to their similarities to the human ESC in ways unmatched by the mouse ESCs, they are 
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suggested to be a more clinically relevant model to study about stem cell pluripotency 
in the mice. It is hence important for the stem cell biologist to keep in mind inherent 
differences between ESCs of different species (on top of differences between various 
cell lines), and to reconfirm studies seen in mouse ESCs in their human counterparts.  
Today, however, probably due to the extensive resources already invested in 
ESCs in stem cell research and their greater potential associated with their primitive 
state (as compared to EpiSCs), the mouse ESC still remains the more popular cell line 
in stem cell differentiation studies over mouse EpiSCs. Despite the lack of clinical 
relevancy, mouse ESCs still present with advantages over human ESCs in certain 
aspects of research. For example, in developmental studies, it is easy to determine the 
biological relevance of mouse ESC-derived neurons in the mouse embryonic brain by 
large-scale in-situ hybridisation studies, or even in transplantation studies (Paper II and 
III) (Friling et al., 2009a; Panman et al., 2011). The work in this thesis is largely based 
on the mouse ESC line E14. 
 
1.2.2 Induced pluripotent stem cells (iPSCs) 
iPSCs at the very beginning refers to fibroblast cells that were “induced” to 
become pluripotent stem cell-like by the lentiviral overexpression of three transcription 
factors that form the core of pluripotency – Oct4, Sox2 and Klf4, as well as c-Myc, first 
in mice (Takahashi and Yamanaka, 2006), then in the humans (Takahashi et al., 2007; 
Yu et al., 2007). The field has very quickly expanded to include an array of somatic 
cells – including adult neural stem cells, cardiomyocytes, blood cells, etc that could be 
similarly induced to display properties of ESCs (Aoi et al., 2008; Kim et al., 2008; 
Staerk et al., 2010). Other combinations of factors have been reported to similarly 
induce pluripotency including Oct4/Sox2/Nanog/Lin28 (Yu et al., 2007), 
Nr5a2/Sox2/Klf4 (Heng et al., 2010), Oct4/Sox2/Esrrb (Feng et al., 2009), etc. The 
original set of four factors has also been reduced to three (Nakagawa et al., 2008) (since 
the oncogenic c-Myc is non-compatible for clinical uses) or even to just one (Kim et al., 
2009a), depending on the cell context. iPSCs can be differentiated to a variety of 
clinically relevant cell types including cardiomyocytes, neurons, blood cells, 
hepatocytes, etc using the same protocols that were first discovered using ESCs (Kondo 
et al., 2013; Lan et al., 2013; Si-Tayeb et al., 2010; Takebe et al., 2013).  
However, not surprisingly, there are increasing evidences that different iPSC 
lines are not identical and that they may not be exactly the same as human ESCs in 
terms of methylation status, genome-wide gene expression and propensity to 
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differentiation (Chin et al., 2009; Kim et al., 2011a; Lowry, 2012; Ohi et al., 2011; 
Sandoe and Eggan, 2013). Whether or not such molecular differences will result in 
functional distinctions will require further investigations. What is relevant to the stem 
cell engineer is to keep such differences in mind in planning experiments and to use 
them to our advantage. For instance, residual epigenetic memory from their former self 
may aid differentiation to the same lineage (Bar-Nur et al., 2011; Kim et al., 2011a). 
This means that in theory, we can derive neurons more efficiently from iPSCs made 
from neural tissue. We should also include multiple control lines in differentiation 
studies to make solid conclusions (Sandoe and Eggan, 2013). 
 
 
1.3 Lessons from developmental biology in cell fate decisions- 
What are “Extrinsic” and “Intrinsic” cues? 
Since ESCs are derived from the inner cell mass, which is then primed to 
differentiate and to give rise to the three germ layers, it is important to understand the 
early developmental processes that guide cell fate decisions in-vivo so that we can 
recapitulate the process in-vitro. We can see from developmental studies the recurring 
theme of extrinsic cues in the form of growth factors to induce intrinsic cues in the 
form of transcription factors, which, in turn, leads to and stabilises the phenotype 
together with extrinsic survival cues. 
 
1.3.1 Early development of the vertebrate embryo 
When an oocyte is fertilized by a sperm, it kickstarts a series of mitotic 
divisions to give rise to a ball of cells which enlarges as it moves towards the uterus. 
The first differentiation event occurs by the 64-cell stage, whereby the inner cell mass 
and the outer trophoblast cells become separate cell layers. The inner cell mass gives 
rise to the embryo and its associated yolk sac, allantois and amnion while the 
trophoblast cells give rise to the placenta and produces enzymes and cell adhesion 
molecules critical for the implantation of the embryo into the uterine wall (Gilbert et 
al., 2000).  
After implantation, the inner cell mass segregates to become the visceral 
endoderm (hypoblast) and the epiblast. In a process termed gastrulation, the embryonic 
epiblast cells forms the three germ layers that makes up the body of the adult animal – 
the ectoderm, mesoderm and endoderm. Just before gastrulation, the stage is set with 
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the formation of the extraembryonic anterior visceral endoderm, which secretes Wnt 
and Nodal antagonists (Dkk1 and Lefty1) to mark the anterior pole of the embryo. 
During gastrulation, Wnt and Nodal signals at the posterior end induces the formation 
of the primitive streak along the midline, extending anteriorly to the node. The epiblast 
layer (what is now known as the ectodermal layer) anterior to the primitive streak 
thickens and folds to form the neural tube in response to signals from the underlying 
notochord and the anterior visceral endoderm (Gilbert et al., 2000). This process is 
known as neurulation, which will be elaborated in a later section. At the same time, 
cells divide and migrate through the primitive streak first downwards, then laterally and 
anteriorly, to give rise to two new layers below - the definitive endoderm and the 
mesoderm. In the xenopus and zebrafish embryos (Rodaway and Patient, 2001), there is 
a bipotent layer of cells that gives rise to both the mesoderm and the endoderm, hence 
referred to as the mesendoderm. In mouse embryos, fate mapping (Kinder et al., 2001; 
Lawson et al., 1991) points to cells present in the organizers (from the primitive streak) 
that give rise to the anterior definitive endoderm and axial mesoderm. Studies using 
embryonic stem cells (Kubo et al., 2004; Tada et al., 2005)  have also shown that in 
differentiation cultures, brachyury or goosecoid-expressing cells have the potential to 
give rise to both the endoderm and the mesoderm.   
In the adult animal, the ectoderm contributes to the epidermis, teeth, the 
nervous system, etc; The mesoderm develops into muscles, connective tissues, blood, 
bone, heart and gonads; The definitive endoderm forms the liver, pancreas, bladder and 
the lining to lungs and the digestive gut. As such, the inner cell mass is described to be 
“pluripotent” – to have the potential to give rise to all cells of the adult body. 
 
Paper I describes the application of extrinsic cues through the canonical Wnt 
pathway in selecting for mesendodermal cell fates from ESCs. Such mesendodermal 
progenitor clones are not only self-renewable and reversible, but also show a propensity 
to differentiate to the endothelial, cardiac, osteogenic, and chondrogenic lineages. Paper 
II and III explores biologically-relevant external signals that provides a permissive 
environment for clinically important neuronal subtypes to arise, then integrates 
extrinsic signals with intrinsic signals in the form of transcription factors to improve 
differentiation efficiencies of ESCs.  
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1.3.2 A simplified view on neurulation and neuronal specification 
At its very beginnings, the nervous system starts out as a tubular structure 
known as the neural tube. Following gastrulation, neurulation occurs in which 
presumptive epidermal cells at the two edges of the neural plate move towards each 
other, folding the neural plate and pushing the edges of the neural plate together so that 
they close up to form the neural tube. Cells of the neural tube eventually give rise to the 
neurons, astrocytes and oligodendrocytes that make up the nervous system (Gilbert et 
al., 2000).  
I will focus on the description of the anterior parts of the neural tube that 
eventually make up the brain. After the neural plate joins at its anterior ends, the tube 
swells to give rise to three primary brain vesicles – the forebrain, midbrain and 
hindbrain, which goes on to become more finely divided into five secondary vesicles – 
Telencephalon, diencephalon, mesencephalon, metencephalon and myelencephalon. 
Specification of these vesicles, as well as the Nestin-positive neuronal progenitor cells 
that line the vesicles are guided by extrinsic signals from the underlying mesoderm 
(retinoic acid), notochord (sonic hedgehog) and epidermis (bone morphogenetic 
factors). Once the vesicles are properly setup, structures such as the isthmus at the mid-
hindbrain boundary also acts to propagate the positional signal (fibroblast growth factor 
8) for appropriate neuronal subtypes to be born (Gilbert et al., 2000).  
 
 
Figure 1: Schematic of the mouse embryonic brain. (A) Sagittal view of positions of 
neuronal subtypes described in Papers II and III. Mesencephalic dopamine neurons (DAN) and 
oculomotor/trochlear neurons (OMN/TN) are born in the midbrain while noradrenergic neurons 
(NAN) and serotonergic neurons (SN) are born in the hindbrain. Some visceral motor neurons 
(vMN) are also born in the hindbrain. Neuronal subtype specification is influenced by growth 
factors in the vicinity of developing neurons such as FGF8 (red) in the isthmus, BMPs (blue) in 
the roof plate and sonic hedgehog, Shh (green) from the notochord. Note that only the mid- and 
hind-brain regions are considered in this schematic. (B) Cross-sectional view of the neural tube 
illustrates the gradient of Shh from the ventral floor plate and BMPs from the dorsal roof plate. 
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A number of clinically-relevant neural subtypes are born in the midbrain and 
hindbrain regions - dopamine neurons (DANs), motor neurons (MNs), serotonergic 
neurons (SNs), noradrenergic neurons (NANs). (Refer to Figure 1 for details). Other 
than NAN, which are born in dorsal rhombomere 1, the rest of them are found in the 
ventral half of the neural tube. From developmental studies in chick and mouse, we 
observe two factors key to their specification – The exposure to positionally appropriate 
environmental cues at a timely fashion (spatiotemporal), both of which can be 
manipulated in-vitro to drive cell fate specification from ESCs. 
 
 
1.3.3 The roles of signalling molecules in specification  
Signalling molecules in dorsal-ventral patterning of the neural tube 
The graded response to morphogens and its interpretation into cell fate 
decisions is perhaps best illustrated by studies on the action of sonic hedgehog (Shh) in 
the specification of ventral neurons in the chick spinal cord. In-vivo, Shh from the 
notochord induces the formation of the floor plate, which in turn takes over the 
secretion of Shh. Shh diffuses across the neural tube, setting up a gradient of Shh 
exposure that induces the differentiation of ventral neuronal subtypes (Figure 1B) 
(Chiang et al., 1996; Yamada et al., 1991). As such, the more ventral is the neural 
progenitor, the greater is the exposure to Shh. In fact, varying Shh concentrations on 
ex-vivo cultures produces the five classes of ventral neurons in the spinal cord in a 
predictable fashion, based on their dorso-ventral positions in the neural tube (Chiang et 
al., 1996; Ericson et al., 1996; Marti et al., 1995; Placzek et al., 1991). Shh signal then 
induces the expression of relevant transcription factors, which goes on to stabilise the 
phenotype by cross-repressive interactions and feed-forward amplification or repression 
of the external signal. Such integration of extrinsic and intrinsic cues establishes the 
sharp borders between different classes of neurons (Briscoe and Ericson, 2001; Briscoe 
et al., 2000; Ericson et al., 1997; Lek et al., 2010; Oosterveen et al., 2012). Molecularly, 
Shh action is mediated through the Gli family of transcription factors (Ding et al., 
1998).  
In the dorsal third of the neural tube, the roof plate acts as another important 
organizer that secretes bone morphogenetic factors (BMPs) to induce the specification 
of dorsal neurons (Lee et al., 1998; Liem et al., 1997; Panchision et al., 2001). There 
are a few members in the family of BMPs (for instance, BMP6, 7 and Gdf7) secreted 
by the roof plate depending on the species (chick or mouse), the region (hindbrain 
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versus spinal cord) as well as on the timing. In a similar fashion as Shh, BMPs also sets 
up a transcriptional code in dorsal neurons (Timmer et al., 2002). In the specification of 
locus coeruleus (LC) NANs in the mouse hindbrain, BMP 5, 6 and 7 are expressed in 
positions close to where the Phox2a-positive noradrenergic precursor cells are born 
(Tilleman et al., 2010). However, these NANs are lost only when both BMP5 and 
BMP7 are deleted in the mouse, suggesting functional redundancy between BMP5 and 
BMP7 in noradrenergic development (Solloway and Robertson, 1999; Tilleman et al., 
2010).  
 
Signalling molecules in anterior-posterior patterning of the neural tube 
Studies in the chick embryos reveal that the initial default identity of cells in the 
neural tube belongs to the rostral character and that caudal cells are induced by 
signalling molecules from a few key organizers (Muhr et al., 1999). The same 
phenomenon is observed in ESC neural differentiation in that ESCs cultured simply in 
neural differentiation media (N2/B27 media) expressed forebrain markers (Gaspard et 
al., 2009). 
The isthmus (also referred as the mid-hindbrain boundary) provides important 
positional information along the rostral-caudal axis for the specification of neurons in 
the midbrain and rostral hindbrain. The actions of the isthmus is mediated largely by 
fibroblast growth factor 8 (FGF8) (Gilbert et al., 2000). FGF8 (Figure 1; FGF8 in red) 
has been shown to be key in the specification of a number of neural subtypes in the 
vicinity, such as DANs, MNs, rostral SN as well as NANs (Hidalgo-Sanchez et al., 
1999; Liu et al., 1999). 
Posteriorly, retinoic acid (RA) from the paraxial mesoderm has profound effects 
on the development of the caudal hindbrain. Quail hens put under a complete vitamin 
A-deficient diet and developing chick embryos with inhibited RA receptors present 
with misspecification of the posterior hindbrain regions such that they adopt a more 
anterior identity (Dupe and Lumsden, 2001; Maden et al., 1996; van der Wees et al., 
1998). In neural tube specification, the more posterior the region, the greater is the 
requirement for RA (Dupe and Lumsden, 2001; Glover et al., 2006). RA is necessary 
for the specification of caudal hindbrain and spinal cord and inhibits midbrain and 
rostral hindbrain formation (Muhr et al., 1999; Niederreither et al., 2000). In ESC 
differentiation protocols, RA is a strong inducer for the neural lineage. We have 
observed, together with many others, that adding RA to ESCs accelerates cell cycle exit 
and the acquisition of neuronal identity (Kim et al., 2009b).  In driving neural subtype 
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identity, exposure to higher RA concentrations means that the neuronal cells derived 
will express markers of the posterior hindbrain and spinal cord, such as the somatic 
motor neurons (Li et al., 2005; Panman et al., 2011).  
 For the forebrain to rostral hindbrain regions, Wnts from the paraxial 
mesoderm (together with FGF8) seem to be providing information in a dose-dependent 
manner in rostrocaudal axis specification (Muhr et al., 1999; Nordstrom et al., 2002).  
The Wnt signalling pathway is also key to the dorsal-ventral patterning of the neural 
tube. An overview to the Wnt signalling pathway will be provided in a later section and 
I will discuss further the effects of Wnt signalling on neural specification. 
 
1.3.4 The canonical Wnt pathway in brief 
The highly conserved Wnt family of secreted proteins has roles in germ layer 
and axis specification in early vertebrate development. Central to the action of the 
canonical Wnt signalling pathway is beta-catenin (encoded by the Ctnb1 gene) and the 
TCF transcription factors(Alberts, 2008; Gilbert et al., 2000). Wnt proteins described in 
this thesis that signal through the canonical Wnt pathway include Wnt1 and Wnt3a. 
Beta-catenin binds to the transmembrane cadherins at adherens junctions to 
regulate cell adhesion, and interacts intracellularly with alpha-catenin to regulate cell 
structure. Excess beta-catenin in the cytoplasm is phosphorylated and trapped in a 
destruction complex made up of glycogen synthase kinase (GSK-3), Axin, 
adenomatous polyposis coli (APC), and several other players. The canonical Wnt 
pathway is activated when Wnt proteins bind to its receptor Frizzled and co-receptors 
Lrp5/6. This in turn recruits Axin and activates Dishevelled (which inhibits GSK-3), 
destabilising the destruction complex and leaving beta-catenin dephosphorylated and 
intact. Beta-catenin is then free to translocate into the nucleus to cooperate with 
TCF/LEF transcription factors and activate transcription of Wnt target genes (Alberts, 
2008; Gilbert et al., 2000). Other than Wnt proteins, chemical inhibitors of GSK-3 are 
commonly used in experiments to activate the Wnt pathway. GSK-3 inhibition, 
however, has other less well-known effects including regulating hedgehog signalling, 
transcription, microtubule synthesis and apoptosis. Different GSK-3 inhibitors also 
target different regions for inhibition. (Doble and Woodgett, 2003; Forde and Dale, 
2007) 
In vertebrates, there are four members in the TCF protein family including 
TCF1, LEF1, TCF3 and TCF4.  Different TCFs are found in different embryonic 
tissues while all of the TCF family members are present in mouse embryonic stem 
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cells. TCF3 predominently represses transcription while LEF1, TCF3 and TCF4 
reportedly activate transcription (Cadigan and Waterman, 2012).  
 
The Wnt pathway in early embryonic development 
 During gastrulation, Wnt signalling is active in the visceral endoderm 
(VE). The anterior end of the VE secretes Dkk1 and Lefty1 to inhibit Wnt and Nodal 
signalling respectively. At the posterior end, Wnt and Nodal signalling remains active 
for the primitive streak to form. This event underlies the basis of anterior-posterior axis 
patterning in the developing embryo. In embryos lacking Wnt3 or beta-catenin, the 
primitive streak and the mesoderm do not form. Antagonising Wnt signalling is hence 
critical at the anterior end of the embryo for the development of the heart and the 
forebrain. 
 
The Wnt pathway in embryonic stem cell pluripotency/differentiation  
 Activation of the Wnt pathway is reported to maintain pluripotency of 
mouse and human ESCs (Sato et al., 2004; ten Berge et al., 2011; Wray et al., 2011; 
Ying et al., 2008) and at the same time, to initiate mesendodermal differentiation 
(Bakre et al., 2007; Davidson et al., 2012; Sumi et al., 2008) and repress 
neuroectodermal differentiation (Aubert et al., 2002; Cajánek et al., 2009; Slawny and 
O'shea, 2011). Both ESCs and mouse embryonic fibroblasts commonly used in co-
culture express Wnts (Sato et al., 2004; ten Berge et al., 2011). Wnt signalling was also 
described to be downregulated upon differentiation (ten Berge et al., 2011).  
Beta-catenin’s critical role in cell adhesion also adds to the complexity of the 
action of Wnt pathway in stem cell pluripotency. The appearance of compact, rounded 
colonies is one of the hallmarks of pluripotency in ESC, and this is maintained by 
interactions between beta-catenin, alpha-catenin and E-cadherins to result in tight cell 
adhesion.  It has been reported that Ctnnb-deficient mouse ESCs maintain self-renewal 
properties but fail to give rise to the three germ layers properly (Lyashenko et al., 
2011). However, another study observed a downregulation of pluripotency markers in 
the same Ctnnb(-/-) mouse ESCs, which can be rescued by preserving the cell adhesive 
function of beta-catenin (Del Valle et al., 2013).  
The effects of Wnt on embryonic stem cells appears conflicting at a glance but 
they are not mutually exclusive. Due to Wnt’s involvement in a multitude of early 
embryonic lineage decisions as discussed above, the effects seen in-vitro is dependent 
on the cell context, length of treatment and molecules used to activate the Wnt pathway 
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(Wnt3a protein/Chemical inhibitors). At the molecular level, such variability translates 
into numerous possibilities in the interplay of TCFs involved. Adding to the complexity 
is the multitude of players involved in pluripotency/differentiation decisions including 
BMPs, LIF/Stat3 and FGF/ERK (Ying et al., 2008). In our study, we observed that 
long-term activation of the Wnt pathway in mouse ESCs increased their propensity to 
differentiate to mesendodermal progenitors. I will discuss these seemingly 
contradictory effects of Wnt in greater details in the results section for Paper I.  
 
The Wnt pathway in neural specification 
The inhibitory effects of Wnt on neural induction in ESCs does not preclude its 
use in neural differentiation of ESCs. As memtioned in an earlier section, the Wnt 
signalling pathway has roles in both the rostrocaudal and dorsoventral patterning of the 
neural tube. 
Wnt1 and Wnt3a proteins are expressed in the developing mouse roof plate 
(Summerhurst et al., 2008). The combined loss of Wnt1 and Wnt3a leads to a reduction 
in the number of dorsal interneurons in the developing chick spinal cord (Muroyama et 
al., 2002). Dickkopf1 (Dkk1) acts as a Wnt antagonist and Dkk1 null mouse mutants do 
not develop structures rostral to the midbrain (Mukhopadhyay et al., 2001).  
In a different cellular context in the mouse ventral midbrain, Wnt1 and Wnt5a 
are reported to be required for the proliferation and differentiation of DANs, while 
Wnt3a enhances proliferation of dopamine neuronal progenitors (Andersson et al., 
2008; Andersson et al., 2013; Castelo-Branco et al., 2003; Prakash et al., 2006). This is 
partly due to Wnts’ requirement in the midbrain to inhibit Shh in the floor plate to 
allow DAN neurogenesis to occur (Joksimovic et al., 2009). In ESCs neural 
differentiation protocols, Wnt proteins (Wnt1, Wnt5a) are added together or after 
neural induction by other molecules (e.g. Noggin), to enhance the derivation of DANs 
(Andersson et al., 2013; Kirkeby et al., 2012; Ribeiro et al., 2012). Kirkeby and 
colleagues activated the Wnt pathway in human ESC-derived neural progenitors using 
a GSK-3 inhibitor and showed that by varying its dosage, it is possible to control the 
positional (rostral-to-caudal) identity of the neurons generated (Kirkeby et al., 2012). 
 
Extrinsic signals in the developing embryo are managed tightly by constraints 
of timing, space, concentrations and interactions with the environment such that signals 
that induce a multitude of different neural subtypes (e.g. Wnts) at different positions 
can specifically instruct the birth of a specific neuron at a specific place. In-vitro 
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protocols that mimic in-vivo conditions often lack the full set of instructions required, 
hence leading to non-homogenous cultures in ESC differentiation. The context-
dependent and ubiquitous nature of the actions of the Wnt pathway also highlights the 
limitations in directing stem cell differentiation merely by manipulating signalling 
molecules. In the next section, I will discuss the strategy we used to overcome such 
limitations in neuronal cell fate specification using transcription factors.  
  
1.3.5 Transcription factors in neuronal identity specification 
In this section I will give a brief overview on the developmental requirements of 
two neuronal subtypes described in this thesis (midbrain DAN and hindbrain NAN), 
focusing on the transcription factors that are key to their specification. Transcription 
factors belong to a group of proteins that bind to specific DNA sequences to transmit 
information from DNA to mRNA, which is subsequently translated into proteins (the 
final effector of cell processes). Transcription factors can work singly, or in 
combination with other transcription factors or cofactors, depending on the cell context. 
This means that the same transcription factor can have multiple roles in multiple cell 
types at different stages of development. Transcription factors, in driving cells down a 
particular lineage, repress alternative cell fates at the same time.  
 
Transcription factors in the development of dopamine neurons 
Mesencephalic DANs are of tremendous research interest because the loss of 
these neurons in Parkinson’s disease contributes to the debilitating effects on control of 
movement. Experiments in both animals and humans suggest that replacing these 
neurons not only alleviate but also reverse the physical deterioration significantly 
(Bjorklund and Kordower, 2013; Kim et al., 2002). As such, there are important 
clinical applications for an unlimited source of midbrain DANs, stem cell-derived 
neurons being the forerunner in the search for such sources.   
DANs in the central nervous system (CNS) are localized in several cell groups, 
including those which lie in the midbrain, the hypothalamus and the olfactory bulb 
regions. This thesis focuses on the midbrain DANs that lies in the substantia nigra and 
ventral tegmental area (groups A8-A10). Developmental studies conducted in the chick 
and the mouse models revealed a number of transcriptions factors that are vital to the 
specification of midbrain DANs at various stages (see Figure 2 for details) – including 
Lmx1a, Lmx1b, Foxa2 (Hnf3b), Otx2, En1/2, Pitx3 and Nurr1. Other than the 
expression of these transcription factors, differentiated DAN are identified in cultures 
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as cells that express the enzymes tyrosine kinase (TH), aldehyde dehydrogenase (Aldh), 
aromatic L-amino acid decarboxylase (AADC), as well as the dopamine transporter 
(DAT), vesicular monoamine transporter (VMAT) and/or tyrosine kinase receptor 
(RET). It is noteworthy that TH, other than being essential for the synthesis of 
dopamine in DANs, it is also expressed by other neural subtypes such as the NANs. 
The gold standard in proving their identity therefore lies in transplanting in-vitro 
derived DANs into animals and showing that they are able to integrate and to reverse 
motor deficits. 
 
 
Figure 2: Key transcription factors in dopamine neuron (DAN) development in the mouse 
and their timing in expression. Lmx1a is expressed early in the DAN progenitor and 
continues to be expressed in the differentiated mature DAN. 
 
In Paper II, we described the application of a combination of appropriate 
extrinsic factors – Shh and FGF8, together with the forced expression of Lmx1a in 
Nestin-positive mouse ESC-derived neural progenitors to generate tyrosine kinase 
(TH)-positive DAN at a highly efficient rate. The idea of using transcription factors to 
drive cell fate specification from stem cells is not new. Prior to our attempt at using 
Lmx1a, Nurr1 and/or Pitx3 overexpression to drive DAN synthesis were studied by 
numerous others. It is not hard to see why these two transcription factors were favoured 
over the rest - Nurr1 knockout mice display one of the most severe phenotype in terms 
of the loss of mesencephalic DANs (Wallen et al., 1999; Zetterstrom et al., 1997). The 
loss of Pitx3, on the other hand, specifically affects the subset of dopamine neurons that 
are most vulnerable in Parkinson’s disease – namely the A9 group in the substantia 
nigra (Hwang et al., 2003). Forced expression of  Nurr1 or Pitx3, either singly or in 
combination using viral vectors in neural precursor cells did not induce their 
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differentiation into DAN in some instances (Sakurada et al., 1999; Sonntag et al., 
2004). Others enjoyed greater success by using embryonic neural precursor cells (Kim 
et al., 2003), or by selecting for “best-performing” mouse ESC-derived clones that were 
genetically manipulated to overexpress Nurr1, boosting the percentage of TH-positive 
neurons amongst Tubb3-expressing neurons from 5-10% to up to 90% (Chung et al., 
2005; Chung et al., 2002; Kim et al., 2006). When Nurr1 is over-expressed together 
with the pro-neural gene Ngn2 in fetal mouse ventral midbrain progenitors, Ngn2 
expectedly takes on the role of driving neuronal differentiation, while the addition of 
Nurr1 leads to the acquisition of dopaminergic markers (Andersson et al., 2007).  
Overexpressing Pitx3 in mouse ESCs enhanced the proportion of aldehyde 
dehydrogenase 2 (AHD2)-expressing TH-positive DANs but not the total number of 
DANs (Chung et al., 2005). AHD2 is mostly expressed in A9 DAN and less so in A8 
and A10. An important observation from such studies is the fact that Nurr1 and Pitx3 
have specific and unique effects when present either by itself (Nurr1 upregulates TH; 
Pitx3 upregulates AHD2) or in combination (Nurr1 and Pitx3 upregulates DAT) 
(Martinat et al., 2006). In summary, Nurr1 or Pitx3 overexpression drives the gene 
expression of their target genes (TH, RET by Nurr1, AHD2 by Pitx3) hence inducing a 
“dopaminergic phenotype” without direct effects on neurogenesis or other dopamine 
transcription factors.  
To engineer DAN from stem cells efficiently, we need to consider the 
individual actions of each intrinsic determinant. Since Nurr1 and Pitx3 start to be 
expressed only in the early postmitotic DAN between E10.5 and E11.5, we sought to 
achieve a better induction with some of the earlier expressed dopamine transcription 
factors such as Lmx1a. Whether or not some of these engineered DANs acquire the 
complete dopaminergic phenotype requires further study; although I will argue that 
such genetically engineered neurons are good enough as long as they can perform a 
functional rescue in animal models of PD, as shown in some studies (Martinat et al., 
2006).  
Lmx1a is detected by E9 in the embryonic mouse brain (Figure 2). Lmx1a was 
described to be a key determinant of DAN because it not only induces ectopic DANs 
when misexpressed in the chick midbrain, it also induced dopamine neuronal 
generation from mouse and human ESCs put in a permissive environment of Shh and 
FGF8 (Andersson et al., 2006). The examples described earlier on Nurr1 
overexpression studies highlights the importance of the context of cell differentiation - 
As shown by Nefzger and colleagues, even when Lmx1a is expressed in neural 
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progenitors, it does not result in the dopaminergic lineage by default (Nefzger et al., 
2012). In addition, when Roybon and colleagues overexpressed Lmx1a, Msx1, Ngn2 
and Pitx3 either individually or in combination in rat and human neural progenitor 
cells, they failed to enhance the number of DANs in the culture (Roybon et al., 2008). 
We need to keep in mind that Lmx1a has specification roles in other cell types such as 
those in the inner ear and in the roof plate (Koo et al., 2009; Millonig et al., 2000). The 
same is true for a few of the other key players in dopamine neuron specification, such 
as Pitx3 in muscle and lens development (Coulon et al., 2007; Medina-Martinez et al., 
2009). What is unique about our approach is that Lmx1a turns on only in Nestin-
positive neural progenitor cells (and not in pluripotent stem cells, for example) that are 
exposed to the “midbrain environment”. I will elaborate on this in the results section for 
Paper II.  
 
Phox2a and Phox2b in the development of motor neurons and noradrenergic neurons 
Noradrenergic neurons (NANs) in the locus coeruleus (LC) is the major source 
of norepinephrine to extensive areas in the central nervous system including the cortex 
and the hippocampus. It has becoming increasingly evident that in neurodegenerative 
diseases such as Parkinson’s disease and Alzheimer’s disease noradrenaline content in 
terminal regions is reduced, with an even greater degree of noradrenergic cell loss  than 
that in the site that causes the typical clinical features (i.e. substantia nigra and nucleus 
basalis) (Bertrand et al., 1997; Cash et al., 1987; Chan-Palay and Asan, 1989; Lyness et 
al., 2003; Patt and Gerhard, 1993; Tomlinson et al., 1981; Zarow et al., 2003; Zweig et 
al., 1993). Diminished NANs in these patients contributes to dementia and affective 
mood disorders such as depression (Marien et al., 2004; Zweig et al., 1993). In the 
neurodevelopmental disorder Rett syndrome, MECP2 deficiency in the locus coeruleus  
is suggested to be the greatest contributor to debilitating defects such as respiration and 
cognition (Amir et al., 1999; Taneja et al., 2009).  
Visceral motor neurons (vMN) in the hindbrain innervate the branchial muscles, 
cardiac muscles and smooth muscles of the viscera. A special group of vMN is found in 
the oculomotor nuclei in the midbrain. The oculomotor (nIII) and trochlear (nIV) nuclei 
in the midbrain, together with the abducent nuclei in the hindbrain supply the 
extraocular muscles of the eyes. Motor neurons (MN) are lost in a myraid of motor 
neuron diseases such as amyotrophic lateral sclerosis, primary lateral sclerosis, etc. 
Developmental disorders that are associated with defects in visceral motor neuronal 
development exist but are rare. These include the Pierre-Robin syndrome, Moebius  
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and some types of autism (Abadie et al., 2002; Bonanni and Guerrini, 1999; Rodier et 
al., 1996). Mutations in the PHOX2A gene have been described to cause congenital 
fibrosis of the extraocular muscles in humans (Nakano et al., 2001).  
Despite being involved in some of the most common neurodegenerative 
diseases, there are no reported protocols to efficiently derive central NANs from ESCs. 
In-vivo, the LC and oculomotor and trochlear nuclei are sparse and scattered, making 
ES-derived neurons an attractive alternative to dissected material for study. 
The Phox2 transcription factors are expressed in largely overlapping regions in 
the central nervous system, although differing in their onset and persistence of 
expression (Pattyn et al., 1997; Tiveron et al., 1996). Targeted deletions of Phox2a and 
Phox2b have revealed roles not only in the specification of the noradrenergic  and 
visceral motor neuronal cell fate but also requirements in maintaining the phenotype in 
adult neurons (Coppola et al., 2010; Morin et al., 1997; Pattyn, 2000). In cell lines, both 
Phox2a and Phox2b can bind to the promoter of the norepinephrine-synthesising 
enzyme dopamine beta-hydroxylase (Dbh) and stimulate Dbh activity (Kim et al., 
1998; Swanson et al., 1997; Yang et al., 1998). Phox2a can even induce noradrenergic 
synthesis in ectopic locations in the zebrafish (Guo et al., 1999). Exogenous Phox2a in 
the chick midbrain is able to not only generate the oculomotor nuclei, but also guide 
motor neurons in ectopic positions to their correct spatial positions (Hasan et al., 2010).  
Mammalian homologues Phox2a and Phox2b have identical DNA-binding 
homeodomains but distinct C-terminal domains (Pattyn et al., 1997). The distinction in 
their functions seems to be related to the order in their onset of expression in the 
developing nervous system. In NANs in the hindbrain, Phox2a is expressed in 
progenitors and turns on Phox2b in cells that have just exited the cell cycle. Phox2b 
then diminishes by E11.5 while Phox2a stays on for the lifetime of the animal. The 
oculomotor and trochlear nuclei in the midbrain also expresses Phox2a by E9.0, before 
Phox2b appears at E10.5 in differentiating neurons. Phox2a-/- mice  lack the LC and 
the oculomotor and trochlear nuclei, amidst other missing structures (Morin et al., 
1997; Pattyn et al., 1997). Phox2a is however dispensable for hindbrain visceral motor 
neuron synthesis (Pattyn et al., 1997). In hindbrain MN, Phox2b comes on first in 
dividing progenitors then turns on Phox2a in postmitotic neurons. In Phox2b mutants, 
hindbrain visceral MN are absent  and the LC does not develop properly (Pattyn et al., 
2000). In fact, all neuronal structures that express Phox2b are affected except for the 
nIII and nIV neurons, suggesting a dominant effect of Phox2b in regulating neuronal 
function (Pattyn, 2000; Pattyn et al., 2000; Pattyn et al., 1999). The predominant effect 
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of Phox2b, as well as the unique requirement for Phox2a in the oculomotor and 
trochlear nuclei are further shown in gene replacement experiments  whereby the 
coding regions of Phox2a are swopped for Phox2b, and vice versa (Coppola et al., 
2005). Phox2b is able to replace Phox2a in specifying NANs, but not that of midbrain 
motor nuclei while Phox2a is unable to take over the requirements of Phox2b in 
specifying noradrenergic and hindbrain visceral motor neurons.  
In the developing noradrenergic neuronal precursor, Mash1 switches on 
Phox2a, which goes on to turn on Phox2b (Hirsch et al., 1998; Lo et al., 1998). Mash1, 
however, is down-regulated before Dbh comes on. In view of the importance of Phox2 
proteins in driving the noradrenergic and motor neuronal fate, we extended the same 
strategy in Paper II to derive central NANs and midbrain MNs from ESCs.  
 
 
1.4 Challenges in guiding cell fate decisions and practical 
methods to overcome them. 
ESC-derived cultures are often non-homogenous. Contaminating 
proliferative cells left in culture, even in minute amounts can contribute to disastrous 
overgrowths in grafts or assays. Although a variety of cell types have been reported to 
be successfully derived from ESCs, we still need to improve the efficiency of 
derivation and increase the purity of cells obtained.  
 
Differentiation efficiency  
 To increase differentiation efficiency, we can start the differentiation 
from lineage-restricted progenitors instead of pluripotent ESCs. This strategy is used by 
salamanders in the regeneration of limb tissues and neurons and may serve as an 
important point to consider in stem cell engineering. When a limb is amputated from 
the salamander, it triggers the formation of a layer of progenitor cells known as the 
blastema. Contrary to belief that the blastema consists of homogenous cells that are de-
differentiated to gain pluripotency, it was shown in the axolotl that blastema cells 
retained memory of their former self and were restricted to regenerating cells of the 
same lineages (Kragl et al., 2009). In the red spotted newt, ablation of DANs using 6-
hydroxydopamine triggers dopamine neurogenesis in the normally quiescent 
ependymoglia cells (Berg et al., 2010; Parish et al., 2007). In line with the same 
principle stated above, Paper I describes the creation of mesendodermal progenitor cells 
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(MPCs) from ESCs by Wnt activation, which can give rise to cells of the cardiac, 
endothelial, osteogenic and chondrogenic lineages more efficiently that the primitive 
wild-type ESCs.   
   
Methods for selection of desired cell types 
One of the ways to overcome low differentiation efficiency is to purify for the 
desired cell type. The success of cell sorting depends on the availability of cell-type 
specific surface markers that can be picked up by primary antibodies, and subsequently 
secondary antibodies engineered to be picked up by various technologies including 
flow cytometry and magnetic sorting. ESCs display an advantage over other cell types 
due to the ease of genetic manipulation. For instance, we can generate ESCs that 
express a fluorescent marker under a lineage-specific driver, and select for the desired 
cell types using fluorescence-activated cell sorting (Ganat et al., 2012; Hedlund et al., 
2008). For cell types that are sensitive to mechanical stress from cell sorting, like 
neurons, magnetic sorting presents an alternative that may be gentler on the cells with 
shorter sorting procedures. Magnetically-labelled cells can continue to be grown on 
tissue culture dishes or transplanted into animals as the magnets are biodegradable. In 
Papers II and III, we used the MACS® technology to purify for polysialylated-neural 
cell adhesion molecule (PSA-NCAM) positive neurons. When ESC-derived DANs 
were sorted this way, they eliminated overgrowth observed on grafts conducted in the 
same way with cells that were not sorted (Friling et al., 2009b).  
 
Ethical issues 
Embryonic stem cells, in particular human ESCs are less acceptable on ethical 
grounds since they are first derived from blastocysts, the starting point of a human life. 
Most of the research conducted on human ESCs is however, based on human ESC lines 
well-established in culture (and not from numerous other human blastocysts). There are 
also ethical implications in using ESC-derived cells for cell replacement therapy since 
the ESC was established from another human being. The breakthrough in iPSCs is 
hence timely to provide a bridge for stem cell research to achieve clinical relevance in 
overcoming both the ethical issues as well as practical issues such as immune reactions 
triggered by the grafts.  
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1.5 A short note on transdifferentiation 
There is another route to regenerating lost cells in a dish other than from 
pluripotent stem cells -  in transdifferentiation, we see the direct conversion of one cell 
type to another specialized cell type by forced expression of appropriate transcription 
factors. The concept of transdifferentiation is not completely new but it gained 
momentum following the reprogramming of fibroblasts into iPSCs with merely four 
transcription factors, which essentially shows that the differentiated cell state is not 
irreversible (Takahashi and Yamanaka, 2006).   
Waddington’s epigenetic landscape model perhaps best illustrates the 
developmental potential of cells (Slack, 2002; Waddington, 1957). The differentiating 
cell is visualised to be a ball rolling on a surface of hills and valleys and a pluripotent 
cell with multiple potential lies right on top of a hill. As each cell differentiates and 
matures, it rolls down the hill, comes across several possible pathways, makes its 
choice and eventually sits inside one of the valleys. To induce pluripotency will mean 
taking a somatic cell from a valley to right on top of the hill. This requires more effort 
than for example, moving the cell across the bump to another valley beside it 
(analogous to transdifferentiation). Some interesting examples involving clinically 
relevant cell types include the reprogramming of pancreatic exocrine cells into their 
closely-related beta cells that secrete insulin (insulin-producing cells appear after 3 
days) using only three transcription factors Pdx1, Ngn3 and Mafa (Zhou et al., 2008); 
Reprogramming fibroblasts to neurons by Ascl1, Brn2 and Myt1l (Pfisterer et al., 
2011b; Vierbuchen et al., 2010); Direct conversion of human fibroblasts to DANs 
(Pfisterer et al., 2011a); Transforming adult fibroblasts to cardiomyocytes by Gata4, 
Mef2c and Tbx5 (Ieda et al., 2010). 
Transdifferentiated cells, if the correct combination of transcription factors can 
be found, is an attractive option that requires shorter time, less costs and poses lower 
risks for tumour formation after transplantation. The use of either reprogramming 
techniques depends on the underlying goal – for instance, we can only model early 
developmental processes in the diseased state (with possibilities of scaling up) or 
correct genetic mutations using patient-specific iPSCs. If the goal is for cell 
replacement therapy, then obtaining iPSCs from patients for differentiation, or direct 
transdifferentiation of easily accessible somatic cells (such as fibroblasts) are viable 
options. For example, in-situ transdifferentiation from astrocytes to dopamine neurons 
for Parkinson’s disease is another ingenious way to overcome problems associated with 
the use of stem cells (Torper et al., 2013). 
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2 AIMS 
We aim to characterise and develop methods to enhance differentiation efficiency of 
ESCs by integrating relevant extrinsic and intrinsic signals, specifically 
 
1. To investigate the long-term effects of activation of the Wnt pathway in ESCs 
differentiation using a chemical inhibitor. (Paper I) 
 
2. To achieve efficient generation of clinically-relevant neuronal subtypes from 
ESCs (dopamine, motor and serotonergic neurons) by forcing the timed 
expression of transcription factors key to their development, in the presence of 
a permissive environment. Such ESC-derived neurons can then be used for the 
discovery of new markers as well as to identify new pathways key to their 
development (Paper II). 
 
3. To build on the general principle in Paper II and expand the array of 
clinically-relevant neurons to include noradrenergic neurons and midbrain-
specific motor neurons. We also sought to test the functionality of such ESC-
derived neurons in simple drug assays.  (Paper III) 
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3 RESULTS AND DISCUSSION 
 
In this section, I will provide a summary of the results and methods in each paper, 
highlight some of the key findings, then discuss each paper in line with the theme of the 
thesis.  
 
Paper I: Generation of multipotential mesendodermal progenitors from 
mouse embryonic stem cells via sustained Wnt pathway activation. 
The objective of this study was to investigate the long-term effects of Wnt 
activation on ESCs pluripotency. To activate the Wnt pathway in ESC, we treated 
mouse and human ESCs with either home-made Wnt3A conditioned media, 
recombinant Wnt3A protein, 6-bromoindirubin-3'-oxime (BIO) or a selective inhibitor 
of glycogen synthase kinase 3β (i-GSK3β), in the presence of LIF. All of these resulted 
in robust activation of the pathway as indicated by luciferase reporter assays and 
immunocytochemistry for the active form of beta-catenin in the cells. We compared the 
effects of i-GSK3β and Wnt3A conditioned media and found that both of them acted 
similarly to: induce a panel of meso/endodermal markers (Foxa2, Gata4, Sox17); 
down-regulate a panel of ectodermal markers (Nestin, Pax6, Sox4) (by quantitative 
polymerase chain reaction (qPCR) and/or immunocytochemistry); give rise to a greater 
propensity to differentiate to endothelial sprouts. The Wnt3A conditioned media was an 
important control for the chemical inhibitor we are using because it showed that the 
effects observed were due specifically to activation of the Wnt pathway. The up-
regulation of markers appeared by day 10 of treatment, and continued to rise when 
analysed three weeks later. The Wnt-treated mouse ESCs remained proliferative in ES 
media for up to a year although cells appeared flatter than wild-type ESCs. These ESCs 
also stain positive for alkaline phosphatase, albeit with lighter staining intensity than 
wild-type E14.  
We hypothesized that the full extent of up-regulation of markers and their 
enhanced potential to differentiate to the meso/endodermal lineage were masked by 
heterogeneity in the treated cultures. Hence, to further improve their differentiation 
efficiency, we isolated single-cell clones from long-term i-GSK3β treated mouse ESCs. 
i-GSK3β provided a chemically defined alternative to Wnt conditioned media and is 
more suited to good manufacturing practice (GMP) protocols. Of these, a few clones 
which displayed slight differences in appearances were picked for further analysis. 
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Each of these clones displayed a unique pattern of gene expression in terms of the 
extent of up-regulation of mesendodermal markers. This was similarly reflected in their 
differentiation potentials. All clones showed more efficient differentiation in assays for 
the endothelial, cardiac, osteogenic and chondrogenic lineages, while each clone 
possesses a unique propensity for a certain lineage. For instance, clone 23 with the 
highest fold change in Gata4 and Tbx5 also produced  more embryoid bodies (EBs) 
with cardiac potential (65% in clone 23 versus 15% in wild-type ESC). Such EBs with 
cardiac potential were defined as EBs that were “beating” in culture. The 
“mesendodermal progenitor clones” (MPCs) maintained a stable phenotype in culture 
for more than a year, and the phenotype was reversible upon i-GSK3β withdrawal 
(recovery MPCs).  
Our study provides a way to use a chemically defined inhibitor (i-GSK3β) to 
generate renewable mesendodermal progenitor lines from mouse ESC, hence paving 
the way to large-scale, standardised and reproducible production of desired cell types in 
therapy.  
Prior to our study, a group reported the use of another GSK-3 inhibitor, 6-
bromoindirubin-3'-oxime (BIO), to maintain the pluripotency of both mouse and 
human ESCs (Sato et al., 2004). In the absence of LIF, BIO-treated mouse and human 
ESC maintained the appearance of tight and compact colonies, Oct3/4 expression as 
well as the ability to form teratomas and to differentiate into multiple lineages in-vitro 
(Sato et al., 2004). In 2011, ten Berge and colleagues reported the conversion of mouse 
ESCs to epiblast stem cells with a Wnt antagonist and its rescue with Wnt3a protein 
and LIF (ten Berge et al., 2011).  Wray et. al. also described the requirement for beta-
catenin to relieve Tcf3-mediated repression on pluripotency factors in mouse ESCs 
(Wray et al., 2011).   
Wnt activity in the pre- and post-implantation embryo has been visualised in 
mouse blastocysts with the Axin2LacZ/+ reporter. Notably, Wnt is active in E3.5 and 
E4.5 ICM disappears from the implanted E5.5 to E6.0 embryo before re-appearing 
again at E6.5 in the posterior end of the embryo, coinciding with the primitive streak 
and newly derived mesodermal cells (ten Berge et al., 2011),. In cultured EBs with the 
same reporter, adding Wnt3a proteins served to polarize the EBs in a similar fashion as 
seen in post-implantation embryos (ten Berge et al., 2008).  
What is notable about the studies on using Wnt activation to maintain ESC 
pluripotency is the relatively shorter period of time the ESCs remained in culture (about 
3 passages), compared to our study in which cells were treated for at least 10 days 
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(around 5 passages) and Davidson et. al’s report in which they tracked the effects of 
Wnt on human ESCs for up to 8 weeks (Davidson et al., 2012). If we compare MPCs 
with epiblast stem cells (EpiSCs) first reported only in 2007, there are two striking 
similarities -  1. Mesendodermal markers: EpiSCs were found to co-express 
mesendodermal markers including Brachyury, Gsc and Sox17 despite expressing 
similar levels of Oct4, Sox2 and Nanog as ESCs (Bernemann et al., 2011; Tesar et al., 
2007). 2. Appearance: EpiSCs grow as flat, compact colonies which resemble MPCs 
(Brons et al., 2007).  
Another key difference between studies is the different pathways that were 
activated/inhibited together with Wnt activation. Ying et. al. dissected the signalling 
requirements for ESC pluripotency and their observations explain in part why our 
results differ (Ying et al., 2008). In simple terms, LIF(Stat3)/serum(BMP) act 
downstream of ERK/FGF. ERK/FGF stimulates differentiation, and LIF/BMP acts by 
inhibiting such stimulation. ERK/FGF inhibition alone limits differentiation with 
“occasional neural rosettes”. A combination of ERK/FGF inhibition and Wnt activation 
(by GSK-3 inhibition) is sufficient to maintain ESC pluripotency, independent of Stat3-
mediated self-renewal. 
In a recent paper, Habib et. al. applied local Wnt signals (in the presence of 
LIF) to mouse ESCs using Wnt3a immobilized on beads (Habib et al., 2013). They 
described how a gradient in Wnt signalling resulted in the Wnt-proximal daughter cell 
expressing higher levels of pluripotency associated genes and the Wnt-distal daughter 
cell expressing differentiation markers with the hallmarks of EpiSCs.  
Hence, it is possible that in our study Wnt activation plus LIF supported 
pluripotency to ESCs initially. With long-term in vitro culture, LIF-mediated inhibition 
of differentiation signals started to break down and some ESCs drifted towards a less 
primitive state that was “EpiSCs-like”. This state was then stabilised by Wnt activation. 
With continued selection and the pressure to move down the differentiation path, most 
of the ESCs eventually adopt the “EpiSCs-like” state and facilitated our derivation of 
MPCs. Unfortunately, due to limited analysis of MPCs, I can only speculate on the 
possibilities at this juncture. 
 
Paper II: Transcription factor-induced lineage selection of stem-cell-
derived neural progenitor cells. 
In this study we developed a general strategy for efficient generation of 
clinically-relevant neuronal subtypes from mouse ESCs (dopamine neurons, visceral 
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motor neurons, somatic motor neurons, serotonin neurons) by forcing the timed 
expression of transcription factors key to their development (Lmx1a, Phox2b, Olig2, 
Nkx2.2) in the presence of appropriate extrinsic signals (sonic hedgehog (Shh) , 
fibroblast growth factor 8 (FGF8), retinoic acid (RA)). We made stable ESC lines 
expressing transcription factors under the control of the Nestin enhancer (NesE-Lmx1a, 
NesE-Phox2b, NesE-Olig2, NesE-Nkx2.2) and differentiated them as a monolayer in 
the presence of various growth factors. The differentiation efficiency was analysed by 
co-expression of key markers by immunocytochemistry as well as cell counts. After 
purifying the differentiated ESC cultures for neurons by magnetic sorting (for PSA-
NCAM), we subjected the populations of neurons to genome-wide expression analysis 
(Affymetrix arrays) and showed that most of the genes are indeed expressed in their in-
vivo counterparts by in-situ hybridization in the mouse embryonic brain. This allowed 
us to not only identify new markers, but also to uncover previously unknown features 
such as the similarity between dopamine and serotonin neurons (by hierarchical 
clustering), and the importance of the insulin growth factor signalling pathway to 
dopamine neuron generation. We then showed that ESC-derived neural progenitors that 
are rendered “noncompetent” to differentiate to dopamine neurons (in the presence of 
retinoic acid) can be reprogrammed by a combination of transcription factors 
(lentiviral-driven En1, Otx2 ). This method can even be extended to noncompetent 
human forebrain-derived neuronal progenitor cells, hence presenting an effective 
method to overcome limitations in deriving clinically-relevant cell types.  
Dopamine neurons derived from NesE-Lmx1a ESCs have been shown to 
successfully engraft and reinnervate 6-hydroxydopamine lesioned rat striatum (Friling 
et al., 2009b). Following our study, another group has shown that our strategy (of 
overexpressing Lmx1a in Nestin-positive progenitors) also works in human iPSCs  to 
increase the efficiency of dopamine neuron derivation (Sanchez-Danes et al., 2012a). 
There were a few key factors that contributed to the success in achieving high 
differentiation efficiencies of various neuronal subtypes from mouse ESCs – Choice of 
transcription factor in relevance to role in developmental cascade; Creating a 
permissive environment; Timing of overexpression. 
A number of transcriptions factors are known to be vital to the specification of 
dopamine neurons at various stages – including Lmx1a, Lmx1b, Foxa2, Otx2, En1/2, 
Pitx3 and Nurr1 (Figure 2). As previously discussed in the introduction section, Nurr1 
and Pitx3 has garnered more interest than all the other transcription factors in the hunt 
for transcription factors to induce dopamine neuron differentiation from stem cells. It 
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seems surprising at first glance that a transcription factor such as Lmx1a, with its mild 
effects on dopamine neuron development when knocked out in the mice, turns out to be 
one of the most robust candidate in driving dopamine neuron synthesis from ESCs 
(Deng et al., 2011). Numerous other groups have reproduced the efficient generation of 
midbrain dopamine neurons by overexpressing Lmx1a (Sanchez-Danes et al., 2012a).  
Lmx1a is one of the few transcription factors (Lmx1b, Foxa2, En1, Otx2) that is 
expressed earliest in dopamine neuronal progenitors (E9). In the developing central 
nervous system (CNS), Lmx1a is an important intrinsic determinant not only in 
developing dopamine neurons but also in the roof plate (Andersson et al., 2006; 
Millonig et al., 2000). In ventral CNS, however, unlike most of the other key DAN 
transcription factors, Lmx1a is specifically expressed only in dopamine neurons. 
Hence, in the presence of Shh (to ventralise the culture) and FGF8 (to provide the 
midbrain positional information), Lmx1a expression in Nestin-positive progenitors 
successfully directs their differentiation to dopamine neurons. The importance of 
appropriate extrinsic factors is also highlighted in the study by Wagner and colleagues 
– Nurr1 overexpression induced the midbrain dopamine phenotype in C17.2 neural 
stem cells only in the presence of signals from the ventral mesencephalon (Wagner et 
al., 1999).   
 
Paper III: Transcription factor-induced lineage programming of 
noradrenaline and visceral motor neurons from embryonic stem cells. 
This study builds on the general principle for the generation of specific neuronal 
cell types from ESCs that we developed in Paper II. We applied this strategy with the 
goal of generating noradrenaline neurons (NAN) from mouse ESCs. Mouse ESC-
derived neural progenitors were found to give rise to the highest numbers of NANs in 
the presence of bone morphogenetic protein 7 (BMP7) and fibroblast growth factor 
(FGF8). Based on the developmental requirements of Phox2 transcription factors in 
NAN specification, we forced the expression of Phox2a and Phox2b in ESC-derived 
neural progenitors to improve the efficiency of NAN synthesis. This was done by 
constructing stable mouse ESC lines expressing Phox2a or Phox2b under the control of 
the Nestin enhancer (NesE-Phox2a or NesE-Phox2b). Phox2 transcription factors are 
also key to the specification of visceral motor neurons (vMN), which, as shown in 
Paper II, requires Shh and FGF8. NesE-Phox2b differentiated in the presence of BMP7 
and FGF8 further improved the efficiency by which NAN-like neurons are derived, 
based on marker analysis by quantitative polymerase chain reaction (qPCR), 
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immunocytochemistry and cell counts. NesE-Phox2a, on the other hand, only improved 
vMN generation in the presence of Shh and FGF8. vMN synthesis can similarly be 
improved using the NesE-Phox2b line (shown in this paper and Paper II).  
After purifying the differentiated ESC cultures for neurons by magnetic sorting 
(for PSA-NCAM), we subjected the ESC-derived NAN and vMN to genome-wide 
expression analysis (Affymetrix arrays). The gene lists allow novel NAN markers and 
midbrain-specific vMN markers to be identified, some of which are verified by in-situ 
hybridization studies in the mouse embryonic brain. The practical application of these 
ESC-derived neurons were tested in a simple high-throughput imaging assay to show 
that they can be used in-vitro to screen for drug specificity and toxicity. ASP+ (4-(4-
(dimethylamino)styryl)-N-methylpyridinium) is a fluorescent substrate that mimics 
neurotransmitter binding. When drugs that inhibit binding and uptake of various 
neurotransmitters are added to NAN- and vMN-enriched cultures, they reduced ASP+ 
binding according to the neuronal subtypes present in the cultures. As a further step to 
test this method in generating neuronal cultures of clinical relevance, we overexpressed 
Phox2a or Phox2b in human ESCs and improved the efficiency by which NANs and 
vMN are derived. 
With this paper, we expanded the array of clinically-relevant neurons to include 
NANs and midbrain vMNs that can be efficiently derived from ESCs. This paper also 
emphasized the concept of an appropriate permissive environment using the NesE-
Phox2b line. By ventralizing or dorsalizing the culture with Shh or BMPs respectively, 
the same NesE-Phox2b line drives vMN or NAN synthesis respectively. Despite the 
importance of Phox2a in driving NAN synthesis in vivo, it was shown to be much less 
effective in vitro, compared to its ability to drive vMN synthesis. Phox2a and Phox2b 
have identical DNA-binding homeodomains but distinct C-terminal domains (Pattyn et 
al., 1997). This suggests the possibility of missing cofactors or missing links in our 
understanding of the transcriptional cascade in the development of NAN. In such case, 
the list of NAN-enriched genes may provide vital clues. The dominant effect of Phox2b 
in driving NAN synthesis is also in congruent with results in the reciprocal replacement 
experiments shown by Coppola et. al. (Coppola et al., 2005). 
An additional point made in this paper is the use of ESC-derived neurons as 
tools in drug assays. Research on neuronal function or neuronal response to drugs has 
been facilitated for many years by either dissected material from animals or cell lines 
such as SH-SY5Y or MN9D. We adapted drug assays that use HEK293 cells 
artificially expressing neurotransmitter transporters/receptors, and replaced the non-
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neuronal cells with ESC-derived NAN and vMN (Haunso and Buchanan, 2007; 
Schwartz et al., 2003; Schwartz et al., 2005). Our assays have shown that subtype-
specific response to drugs can be predicted using ESC-derived neurons. Although we 
did not directly compare non-neuronal cell lines with ESC-derived neurons, it is likely 
that ESC-derived neurons is more representative of the biological responses seen in in-
vivo physiological conditions.  
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4 CONCLUSIONS AND FUTURE PERSPECTIVES 
The three studies described in this thesis highlights the integration of 
developmentally appropriate extrinsic and intrinsic factors to build rational approaches 
in stem cell engineering.  
In the first study, we explored the use of a chemically defined inhibitor of GSK-
3 to activate the Wnt pathway to construct a renewable source of mesendodermal 
progenitors. Such strategies may even be coupled with genetically engineered cell lines, 
such as those described in Paper II and III, to give a further boost to differentiation 
efficiencies. The successful use of chemically defined Wnt inhibitors also indicates that 
it is timely to explore the replacement of recombinant proteins with chemically defined 
agents in stem cell differentiation to minimise variation as well as for the long-term 
goal of being compatible with good manufacturing practices.  
In Papers II and III, we integrated knowledge on developmental requirements of 
neuronal subtypes to build an approach that can be applied to derive numerous 
clinically-relevant subtypes. It has been suggested and shown in some cases that the 
specificity of transcription factors lie in the different partners they bind to in a different 
cell context. I envision that the differentiation efficiencies may be further improved by 
the combined overexpression of a few transcription factors. In fact, this was the 
strategy applied by Nefzger et. al. to further enhance the induction of serotonergic 
neurons from ESCs by adding Mash1 and Foxa2 to Gata2 (Nefzger et al., 2011). 
Although there is cause for concern in using genetically modified cells in 
therapy, we can minimise risks with careful experimental designs. For instance, in our 
studies in Paper II and III, the Nestin enhancer is in a “off” state after the cells become 
post-mitotic and this switches off the exogenous expression of the construct. These 
studies are simply proof-of-principle research and we should continually work towards 
improving methods to modify the genome in a safer manner. There are already 
promising advances in non-viral methods for stable modifications of stem cells, such as 
the episomal vectors, adenovirus, BacMam, etc (Fontes and Lakshmipathy, 2013). 
There must be inherent differences between ESC-derived cells and their 
respective bona fida cells but I will argue that as long as such cells are properly 
characterized for functionality in the specific application (for example, drug screening, 
disease modelling, transplantation), it will suffice.  
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